Mira Pharmaceuticals, Inc. SEC filings MIRA
Mira Pharmaceuticals, Inc. has 198 filings in SEC EDGAR's recent list, going back to Jun 29, 2022. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (regulation fd disclosure).
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 3 | Initial insider ownership | Jun 9, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 5 | Annual insider ownership | Feb 17, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 3 | Initial insider ownership | Oct 3, 2025 | Sep 29, 2025 |
| 4 | Insider transaction | Sep 18, 2025 | Sep 18, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Aug 29, 2025 |
| 3 | Initial insider ownership | Jun 10, 2025 | May 15, 2025 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 19, 2024 |
| 3 | Initial insider ownership | Nov 26, 2024 | Nov 18, 2024 |
| 144 | Notice of proposed sale | Nov 19, 2024 | — |
| 144/A | Filing | Sep 6, 2024 | — |
| 144 | Notice of proposed sale | Sep 4, 2024 | — |
| 4 | Insider transaction | Aug 30, 2024 | Aug 28, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 18, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 28, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 21, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 26, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 26, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 25, 2024 |
| 3 | Initial insider ownership | Mar 22, 2024 | Mar 13, 2024 |
| 3 | Initial insider ownership | Mar 22, 2024 | Mar 13, 2024 |
| 3 | Initial insider ownership | Mar 22, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Dec 27, 2023 | Nov 20, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 27, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 20, 2023 | — |
| 3 | Initial insider ownership | Nov 20, 2023 | Nov 14, 2023 |
| 4 | Insider transaction | Nov 17, 2023 | Nov 15, 2023 |
| 3 | Initial insider ownership | Nov 3, 2023 | Oct 25, 2023 |
| 3 | Initial insider ownership | Oct 12, 2023 | Sep 26, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 12, 2023 | — |
| 4 | Insider transaction | Aug 24, 2023 | Aug 7, 2023 |
| 4 | Insider transaction | Aug 21, 2023 | Aug 17, 2023 |
| 4 | Insider transaction | Aug 21, 2023 | Aug 17, 2023 |
| 4 | Insider transaction | Aug 21, 2023 | Aug 17, 2023 |
| 4 | Insider transaction | Aug 21, 2023 | Aug 17, 2023 |
| SC 13D | Ownership over 5% (active) | Aug 14, 2023 | — |
| 4 | Insider transaction | Aug 4, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Aug 2, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Aug 2, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Aug 2, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Aug 2, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Aug 2, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Aug 2, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Aug 2, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Aug 2, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Aug 2, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Aug 2, 2023 | Aug 2, 2023 |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIRA (Nasdaq)
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1904286
- Former names
- Mira1a Therapeutics, Inc. (until May 2, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.